Finerenone, marketed under the brand name Kerendia among others, is a medication used to reduce the risk of kidney function decline, kidney failure, cardiovascular death, non-fatal heart …

Jul 23, 2024 · What is finerenone? Finerenone is used in adults with chronic kidney disease related to diabetes mellitus type 2, to reduce the risk of: kidney problems getting worse; a …

Aug 23, 2023 · Kerendia (finerenone) is a FDA approved tablet taken once a day by adults who have chronic kidney disease from type 2 diabetes. Kerendia is used to slow down kidney …

Mar 1, 2025 · Finerenone is used to lower the risk of serious kidney and heart problems (eg, kidney function decline, end-stage kidney disease, cardiovascular death, heart attack, and …

Sep 1, 2024 · In this international, double-blind trial, we randomly assigned patients with heart failure and a left ventricular ejection fraction of 40% or greater, in a 1:1 ratio, to receive …

Oct 23, 2020 · Finerenone, a nonsteroidal, selective mineralocorticoid receptor antagonist, reduced albuminuria in short-term trials involving patients with chronic kidney disease (CKD) …

Jun 12, 2024 · Kerendia (finerenone) is commonly used for people who have kidney disease associated with type 2 diabetes. It is used in these people to lower the risk of worsening …

Finerenone is used to treat adults with chronic kidney disease (damage to the kidneys which may worsen over time and may cause the kidneys to stop working) due to type 2 diabetes.

Indicated to reduce risk of sustained estimated glomerular filtration rate (eGFR) decline, end-stage kidney disease, cardiovascular death, nonfatal myocardial infarction, and...

Finerenone is a non-steroidal mineralocorticoid receptor antagonist that inhibits receptor-mediated sodium reabsorption and decreases receptor overactivation, thereby reducing the …